Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma

논문상세정보
' Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생물학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
449 0

0.0%

' Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma' 의 참고문헌

  • microRNA functions
    Bushati N Annu Rev Cell Dev Biol 23 : 175 ~ 205 [2007]
  • microRNA functions
    Bushati N Annu Rev Cell Dev Biol 23 175-205 [2007]
  • miR-221 overexpression contributes to liver tumorigenesis
    Pineau P Proc Natl Acad Sci USA 107 : 264 ~ 269 [2010]
  • miR-221 overexpression contributes to liver tumorigenesis
    Pineau P Proc Natl Acad Sci USA 107 264-269 [2010]
  • as biomarkers and the therapeutic potential of exosome vectors
    Lasser C Expert Opin Biol Ther 12 (Suppl 1) : S189 ~ S197 [2012]
  • as biomarkers and the therapeutic potential of exosome vectors
    Lasser C Expert Opin Biol Ther 12 Suppl 1 S189-S197 [2012]
  • Tumorderived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner
    Lima LG Cancer Lett 283 : 168 ~ 175 [2009]
  • Tumorderived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner
    Lima LG Cancer Lett 283 168-175 [2009]
  • The role of microRNAs in human liver cancers
    Braconi C Semin Oncol 38 : 752 ~ 763 [2011]
  • The role of microRNAs in human liver cancers
    Braconi C Semin Oncol 38 752-763 [2011]
  • The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
    Pant S Biochem Pharmacol 83 : 1484 ~ 1494 [2012]
  • The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
    Pant S Biochem Pharmacol 83 1484-1494 [2012]
  • Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection
    Qi P PLoS ONE 6 : e28486 ~ [2011]
  • Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection
    Qi P PLoS ONE 6 e28486- [2011]
  • Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target
    Wang Y J Biol Chem 283 : 13205 ~ 13215 [2008]
  • Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target
    Wang Y J Biol Chem 283 13205-13215 [2008]
  • Non-coding RNAs in human disease
    Esteller M. Nat Rev Genet 12 : 861 ~ 874 [2011]
  • Non-coding RNAs in human disease
    Esteller M. Nat Rev Genet 12 861-874 [2011]
  • Natural history of hepatitis B and C in renal allograft recipients
    Aroldi A Transplantation 79 : 1132 ~ 1136 [2005]
  • Natural history of hepatitis B and C in renal allograft recipients
    Aroldi A Transplantation 79 1132-1136 [2005]
  • MicroRNAs: novel regulators in the hallmarks of human cancer
    Ruan K Cancer Lett 285 : 116 ~ 126 [2009]
  • MicroRNAs: novel regulators in the hallmarks of human cancer
    Ruan K Cancer Lett 285 116-126 [2009]
  • MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S Hepatology 57 : 840 ~ 847 [2013]
  • MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S Hepatology 57 840-847 [2013]
  • MicroRNAs: genomics, biogenesis, mechanism, and function
    Bartel DP Cell 116 : 281 ~ 297 [2004]
  • MicroRNAs: genomics, biogenesis, mechanism, and function
    Bartel DP Cell 116 281-297 [2004]
  • MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
    Wong QW Gastroenterology 135 : 257 ~ 269 [2008]
  • MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1
    Wong QW Gastroenterology 135 257-269 [2008]
  • MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality
    Gramantieri L Clin Cancer Res 15 : 5073 ~ 5081 [2009]
  • MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality
    Gramantieri L Clin Cancer Res 15 5073-5081 [2009]
  • MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
    Meng F Gastroenterology 133 : 647 ~ 658 [2007]
  • MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
    Meng F Gastroenterology 133 647-658 [2007]
  • MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
    Xu T Hepatology 50 : 113 ~ 121 [2009]
  • MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
    Xu T Hepatology 50 113-121 [2009]
  • MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells
    Liu WH Gastroenterology 136 : 683 ~ 693 [2009]
  • MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells
    Liu WH Gastroenterology 136 683-693 [2009]
  • MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
    Tsai WC Hepatology 49 : 1571 ~ 1582 [2009]
  • MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
    Tsai WC Hepatology 49 1571-1582 [2009]
  • MicroRNA-101, downregulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
    Su H Cancer Res 69 : 1135 ~ 1142 [2009]
  • MicroRNA-101, downregulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity
    Su H Cancer Res 69 1135-1142 [2009]
  • MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
    Taylor DD Gynecol Oncol 110 : 13 ~ 21 [2008]
  • MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
    Taylor DD Gynecol Oncol 110 13-21 [2008]
  • MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
    Ladeiro Y Hepatology 47 : 1955 ~ 1963 [2008]
  • MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
    Ladeiro Y Hepatology 47 1955-1963 [2008]
  • MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics
    Iorio MV EMBO Mol Med 4 : 143 ~ 159 [2012]
  • MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics
    Iorio MV EMBO Mol Med 4 143-159 [2012]
  • MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling
    Wong QW Clin Cancer Res 16 : 867 ~ 875 [2010]
  • MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling
    Wong QW Clin Cancer Res 16 867-875 [2010]
  • Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis
    Sherman M. Semin Liver Dis 30 : 3 ~ 16 [2010]
  • Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis
    Sherman M Semin Liver Dis 30 3-16 [2010]
  • Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
    Beasley RP Lancet 2 : 1129 ~ 1133 [1981]
  • Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
    Beasley RP Lancet 2 1129-1133 [1981]
  • Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    Calin GA Proc Natl Acad Sci USA 99 : 15524 ~ 15529 [2002]
  • Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    Calin GA Proc Natl Acad Sci USA 99 15524-15529 [2002]
  • Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy
    Benhamou Y Hepatology 34 : 283 ~ 287 [2001]
  • Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy
    Benhamou Y Hepatology 34 283-287 [2001]
  • Extracellular vesicles: exosomes, microvesicles, and friends
    Raposo G J Cell Biol 200 : 373 ~ 383 [2013]
  • Extracellular vesicles: exosomes, microvesicles, and friends
    Raposo G J Cell Biol 200 373-383 [2013]
  • Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
    Li J Biochem Biophys Res Commun 406 : 70 ~ 73 [2011]
  • Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
    Li J Biochem Biophys Res Commun 406 70-73 [2011]
  • Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
    Vlassov AV Biochim Biophys Acta 1820 : 940 ~ 948 [2012]
  • Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
    Vlassov AV Biochim Biophys Acta 1820 940-948 [2012]
  • Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
    Valadi H Nat Cell Biol 9 : 654 ~ 659 [2007]
  • Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
    Valadi H Nat Cell Biol 9 654-659 [2007]
  • Exosomal microRNA: a diagnostic marker for lung cancer
    Rabinowits G Clin Lung Cancer 10 : 42 ~ 46 [2009]
  • Exosomal microRNA : a diagnostic marker for lung cancer
    Rabinowits G Clin Lung Cancer 10 42-46 [2009]
  • Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinomacontributes tothe malignant phenotype
    Connolly E Am J Pathol 173 : 856 ~ 864 [2008]
  • Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinomacontributes tothe malignant phenotype
    Connolly E Am J Pathol 173 856-864 [2008]
  • Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
    Borel F J Hepatol 56 : 1371 ~ 1383 [2012]
  • Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
    Borel F J Hepatol 56 1371-1383 [2012]
  • Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma
    Gramantieri L Cancer Res 67 : 6092 ~ 6099 [2007]
  • Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma
    Gramantieri L Cancer Res 67 6092-6099 [2007]
  • Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
    Murakami Y Oncogene 25 : 2537 ~ 2545 [2006]
  • Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
    Murakami Y Oncogene 25 2537-2545 [2006]
  • Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
    Tanaka Y Cancer 119 : 1159 ~ 1167 [2013]
  • Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
    Tanaka Y Cancer 119 1159-1167 [2013]
  • Clinical applications for microRNAs in cancer
    Nana-Sinkam SP Clin Pharmacol Ther 93 : 98 ~ 104 [2013]
  • Clinical applications for microRNAs in cancer
    Nana-Sinkam SP Clin Pharmacol Ther 93 98-104 [2013]
  • Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
    Xu J Mol Carcinog 50 : 136 ~ 142 [2011]
  • Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
    Xu J Mol Carcinog 50 136-142 [2011]
  • Circulating microRNAs in cancer: origin, function and application
    Ma R J Exp Clin Cancer Res 31 : 38 ~ [2012]
  • Circulating microRNAs in cancer: origin, function and application
    Ma R J Exp Clin Cancer Res 31 38- [2012]
  • Circulating microRNAs as stable bloodbased markers for cancer detection
    Mitchell PS Proc Natl Acad Sci USA 105 10513-10518 [2008]
  • Circulating microRNAs as stable blood-based markers for cancer detection
    Mitchell PS Proc Natl Acad Sci USA 105 : 10513 ~ 10518 [2008]
  • Circulating microRNAs as biomarkers for hepatocellular carcinoma
    Qu KZ J Clin Gastroenterol 45 : 355 ~ 360 [2011]
  • Circulating microRNAs as biomarkers for hepatocellular carcinoma
    Qu KZ J Clin Gastroenterol 45 355-360 [2011]
  • Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
    Huang XH Hepatol Res 39 : 786 ~ 794 [2009]
  • Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
    Huang XH Hepatol Res 39 786-794 [2009]
  • Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
    Jiang J Clin Cancer Res 14 : 419 ~ 427 [2008]
  • Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
    Jiang J Clin Cancer Res 14 419-427 [2008]
  • Analyzing real-time PCR data by the comparative C(T) method
    Schmittgen TD Nat Protoc 3 : 1101 ~ 1108 [2008]
  • Analyzing real-time PCR data by the comparative C(T) method
    Schmittgen TD Nat Protoc 3 1101-1108 [2008]
  • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
    Livak KJ Methods 25 402-408 [2001]
  • Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method
    Livak KJ Methods 25 : 402 ~ 408 [2001]